| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coffee | 40 | 2023 | 593 | 7.890 |
Why?
|
| Singapore | 99 | 2024 | 297 | 7.800 |
Why?
|
| Diabetes Mellitus, Type 2 | 106 | 2024 | 12238 | 4.640 |
Why?
|
| Diet | 77 | 2024 | 8085 | 4.580 |
Why?
|
| Feeding Behavior | 46 | 2024 | 3210 | 4.520 |
Why?
|
| Caffeine | 23 | 2022 | 702 | 2.940 |
Why?
|
| Fluorine Radioisotopes | 9 | 2018 | 397 | 2.330 |
Why?
|
| Cardiovascular Diseases | 52 | 2024 | 15648 | 2.260 |
Why?
|
| Food Preferences | 8 | 2022 | 397 | 2.110 |
Why?
|
| Exercise | 26 | 2024 | 5937 | 2.060 |
Why?
|
| Insulin Resistance | 22 | 2024 | 3989 | 1.850 |
Why?
|
| Radiochemistry | 3 | 2019 | 47 | 1.830 |
Why?
|
| Dietary Carbohydrates | 10 | 2022 | 895 | 1.750 |
Why?
|
| Blood Glucose | 32 | 2024 | 6427 | 1.680 |
Why?
|
| Taste Perception | 3 | 2021 | 38 | 1.460 |
Why?
|
| Tea | 9 | 2020 | 290 | 1.430 |
Why?
|
| Nutritive Value | 5 | 2020 | 351 | 1.350 |
Why?
|
| Weight Gain | 12 | 2021 | 2355 | 1.340 |
Why?
|
| Beverages | 11 | 2024 | 819 | 1.320 |
Why?
|
| Diet Surveys | 16 | 2024 | 1159 | 1.320 |
Why?
|
| Adiponectin | 14 | 2023 | 1120 | 1.280 |
Why?
|
| Life Style | 20 | 2024 | 3928 | 1.270 |
Why?
|
| Diet, Mediterranean | 3 | 2022 | 746 | 1.260 |
Why?
|
| Genome-Wide Association Study | 57 | 2024 | 12800 | 1.260 |
Why?
|
| Risk Factors | 120 | 2024 | 74831 | 1.230 |
Why?
|
| Eating | 10 | 2020 | 1539 | 1.230 |
Why?
|
| Nutrition Assessment | 13 | 2017 | 738 | 1.180 |
Why?
|
| Prospective Studies | 104 | 2024 | 54795 | 1.110 |
Why?
|
| Arachidonic Acid | 3 | 2019 | 430 | 1.090 |
Why?
|
| Middle Aged | 186 | 2024 | 222903 | 1.080 |
Why?
|
| Adult | 175 | 2024 | 222974 | 1.060 |
Why?
|
| Body Mass Index | 54 | 2021 | 13044 | 1.040 |
Why?
|
| Dietary Proteins | 8 | 2022 | 960 | 1.030 |
Why?
|
| Energy Intake | 15 | 2022 | 2141 | 1.020 |
Why?
|
| Female | 244 | 2024 | 395961 | 1.020 |
Why?
|
| Humans | 349 | 2024 | 765734 | 1.010 |
Why?
|
| Polymorphism, Single Nucleotide | 47 | 2022 | 16041 | 1.010 |
Why?
|
| Flavonoids | 4 | 2013 | 447 | 1.000 |
Why?
|
| Vegetables | 10 | 2024 | 1200 | 0.970 |
Why?
|
| Fruit | 10 | 2024 | 1167 | 0.910 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2019 | 426 | 0.910 |
Why?
|
| Nutritional Status | 8 | 2023 | 1620 | 0.910 |
Why?
|
| Genetic Loci | 14 | 2020 | 2631 | 0.900 |
Why?
|
| Obesity | 28 | 2023 | 13079 | 0.890 |
Why?
|
| Waist Circumference | 9 | 2021 | 934 | 0.870 |
Why?
|
| Male | 191 | 2024 | 363585 | 0.870 |
Why?
|
| Food Labeling | 3 | 2020 | 181 | 0.850 |
Why?
|
| Dietary Fats | 11 | 2020 | 2002 | 0.850 |
Why?
|
| Acculturation | 2 | 2023 | 178 | 0.850 |
Why?
|
| Radiopharmaceuticals | 5 | 2017 | 2699 | 0.840 |
Why?
|
| Lipids | 15 | 2023 | 3315 | 0.840 |
Why?
|
| Radioactive Tracers | 3 | 2018 | 61 | 0.840 |
Why?
|
| Overweight | 12 | 2021 | 2443 | 0.830 |
Why?
|
| Malaysia | 9 | 2020 | 107 | 0.820 |
Why?
|
| Resorcinols | 3 | 2016 | 41 | 0.820 |
Why?
|
| Prediabetic State | 3 | 2023 | 547 | 0.820 |
Why?
|
| Postprandial Period | 1 | 2024 | 319 | 0.810 |
Why?
|
| Aged | 116 | 2024 | 171050 | 0.800 |
Why?
|
| Biological Specimen Banks | 3 | 2022 | 787 | 0.790 |
Why?
|
| Dietary Fiber | 8 | 2016 | 767 | 0.780 |
Why?
|
| Adiposity | 13 | 2021 | 1891 | 0.770 |
Why?
|
| Cohort Studies | 74 | 2024 | 41631 | 0.770 |
Why?
|
| Health Behavior | 10 | 2024 | 2649 | 0.770 |
Why?
|
| Sphingolipids | 2 | 2020 | 177 | 0.760 |
Why?
|
| Television | 5 | 2019 | 409 | 0.750 |
Why?
|
| China | 15 | 2021 | 2386 | 0.750 |
Why?
|
| Lignans | 4 | 2016 | 82 | 0.730 |
Why?
|
| Cross-Sectional Studies | 48 | 2023 | 26284 | 0.710 |
Why?
|
| Birth Weight | 10 | 2020 | 2121 | 0.700 |
Why?
|
| Choice Behavior | 4 | 2020 | 846 | 0.700 |
Why?
|
| Cholesterol | 10 | 2020 | 2898 | 0.680 |
Why?
|
| Sleep | 6 | 2024 | 4824 | 0.670 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 5 | 2016 | 395 | 0.670 |
Why?
|
| Food Packaging | 1 | 2019 | 13 | 0.660 |
Why?
|
| Fatty Acids | 4 | 2022 | 1806 | 0.650 |
Why?
|
| Marriage | 1 | 2021 | 351 | 0.650 |
Why?
|
| Radionuclide Generators | 2 | 2015 | 12 | 0.640 |
Why?
|
| Social Identification | 1 | 2020 | 108 | 0.630 |
Why?
|
| Culture | 2 | 2020 | 622 | 0.630 |
Why?
|
| Coronary Artery Disease | 7 | 2024 | 6545 | 0.630 |
Why?
|
| Waist-Hip Ratio | 5 | 2016 | 520 | 0.630 |
Why?
|
| Coronary Disease | 12 | 2023 | 5911 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 33 | 2024 | 18061 | 0.630 |
Why?
|
| Food Dispensers, Automatic | 1 | 2018 | 15 | 0.620 |
Why?
|
| alpha-Linolenic Acid | 2 | 2016 | 145 | 0.610 |
Why?
|
| Plant Oils | 2 | 2020 | 199 | 0.610 |
Why?
|
| Glycemic Index | 5 | 2017 | 400 | 0.610 |
Why?
|
| Diet Records | 4 | 2017 | 425 | 0.600 |
Why?
|
| Microfluidics | 3 | 2019 | 651 | 0.590 |
Why?
|
| Plasma | 2 | 2023 | 579 | 0.590 |
Why?
|
| India | 10 | 2020 | 2340 | 0.590 |
Why?
|
| Isotope Labeling | 3 | 2015 | 389 | 0.590 |
Why?
|
| Parenting | 2 | 2021 | 709 | 0.570 |
Why?
|
| Amino Acids | 2 | 2020 | 1709 | 0.570 |
Why?
|
| Minerals | 1 | 2019 | 278 | 0.560 |
Why?
|
| Triticum | 2 | 2016 | 92 | 0.560 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2017 | 788 | 0.560 |
Why?
|
| Octreotide | 1 | 2018 | 157 | 0.560 |
Why?
|
| Receptors, Somatostatin | 1 | 2018 | 138 | 0.550 |
Why?
|
| Cholesterol, HDL | 8 | 2019 | 1811 | 0.550 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2017 | 2024 | 0.550 |
Why?
|
| C-Reactive Protein | 13 | 2016 | 3850 | 0.550 |
Why?
|
| Young Adult | 50 | 2024 | 59852 | 0.530 |
Why?
|
| Atherosclerosis | 4 | 2023 | 3425 | 0.520 |
Why?
|
| Nutrition Policy | 3 | 2019 | 467 | 0.520 |
Why?
|
| Boron Compounds | 1 | 2018 | 195 | 0.520 |
Why?
|
| Cause of Death | 6 | 2018 | 3709 | 0.520 |
Why?
|
| Stearic Acids | 1 | 2016 | 56 | 0.520 |
Why?
|
| Drinking Behavior | 4 | 2014 | 102 | 0.520 |
Why?
|
| Taxes | 1 | 2018 | 219 | 0.520 |
Why?
|
| Case-Control Studies | 34 | 2021 | 22224 | 0.520 |
Why?
|
| Mathematical Concepts | 1 | 2016 | 77 | 0.510 |
Why?
|
| Oxylipins | 1 | 2016 | 55 | 0.510 |
Why?
|
| Climate | 1 | 2017 | 146 | 0.510 |
Why?
|
| Cultural Diversity | 1 | 2020 | 370 | 0.510 |
Why?
|
| Diterpenes | 2 | 2020 | 166 | 0.510 |
Why?
|
| Anthocyanins | 2 | 2013 | 80 | 0.510 |
Why?
|
| Blood Pressure | 21 | 2024 | 8533 | 0.500 |
Why?
|
| Intra-Abdominal Fat | 2 | 2018 | 624 | 0.500 |
Why?
|
| Triglycerides | 10 | 2022 | 2441 | 0.500 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 1123 | 0.500 |
Why?
|
| Follow-Up Studies | 42 | 2020 | 39180 | 0.500 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2017 | 223 | 0.500 |
Why?
|
| Myocardial Infarction | 6 | 2024 | 11504 | 0.490 |
Why?
|
| Proportional Hazards Models | 24 | 2019 | 12509 | 0.480 |
Why?
|
| Risk | 22 | 2021 | 9592 | 0.480 |
Why?
|
| Tosyl Compounds | 1 | 2015 | 115 | 0.470 |
Why?
|
| Urinalysis | 2 | 2016 | 368 | 0.470 |
Why?
|
| 4-Butyrolactone | 2 | 2015 | 60 | 0.470 |
Why?
|
| Cardiovascular System | 1 | 2022 | 840 | 0.470 |
Why?
|
| Taste | 3 | 2022 | 190 | 0.460 |
Why?
|
| Smoking | 20 | 2023 | 9077 | 0.460 |
Why?
|
| Folic Acid | 4 | 2017 | 1338 | 0.460 |
Why?
|
| Computers | 2 | 2016 | 588 | 0.460 |
Why?
|
| Electrophoresis, Capillary | 1 | 2014 | 63 | 0.440 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2022 | 1396 | 0.440 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 687 | 0.440 |
Why?
|
| Urban Health | 1 | 2016 | 530 | 0.440 |
Why?
|
| Glucose Intolerance | 5 | 2022 | 580 | 0.440 |
Why?
|
| Health Promotion | 6 | 2020 | 2208 | 0.440 |
Why?
|
| Models, Chemical | 1 | 2015 | 608 | 0.430 |
Why?
|
| Glucose Tolerance Test | 5 | 2016 | 1180 | 0.430 |
Why?
|
| Pericardium | 1 | 2018 | 679 | 0.430 |
Why?
|
| Meat | 4 | 2024 | 588 | 0.420 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 814 | 0.420 |
Why?
|
| Cholesterol, LDL | 6 | 2019 | 2393 | 0.420 |
Why?
|
| Isoflavones | 4 | 2019 | 139 | 0.410 |
Why?
|
| Positron-Emission Tomography | 8 | 2019 | 6546 | 0.410 |
Why?
|
| Genetic Variation | 14 | 2021 | 6607 | 0.410 |
Why?
|
| Medicine, Traditional | 1 | 2013 | 88 | 0.410 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 744 | 0.410 |
Why?
|
| Mental Recall | 4 | 2017 | 1217 | 0.410 |
Why?
|
| Sodium, Dietary | 1 | 2016 | 426 | 0.410 |
Why?
|
| Leisure Activities | 5 | 2022 | 310 | 0.410 |
Why?
|
| Phenylpyruvic Acids | 1 | 2012 | 4 | 0.400 |
Why?
|
| Chronic Disease | 5 | 2021 | 9351 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 4057 | 0.400 |
Why?
|
| Proteomics | 3 | 2024 | 3910 | 0.400 |
Why?
|
| Glucose | 6 | 2023 | 4334 | 0.400 |
Why?
|
| Residence Characteristics | 3 | 2022 | 2115 | 0.400 |
Why?
|
| Anthropometry | 6 | 2016 | 1339 | 0.400 |
Why?
|
| Pressure | 1 | 2015 | 1169 | 0.400 |
Why?
|
| Titanium | 1 | 2015 | 490 | 0.390 |
Why?
|
| Diabetes Mellitus | 9 | 2023 | 5891 | 0.390 |
Why?
|
| Soy Foods | 4 | 2017 | 44 | 0.390 |
Why?
|
| Catechols | 1 | 2012 | 63 | 0.390 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 281 | 0.390 |
Why?
|
| Chlorogenic Acid | 2 | 2009 | 6 | 0.390 |
Why?
|
| Stroke | 6 | 2023 | 9747 | 0.390 |
Why?
|
| Restaurants | 2 | 2017 | 235 | 0.390 |
Why?
|
| Magnesium | 3 | 2020 | 813 | 0.390 |
Why?
|
| Infant, Low Birth Weight | 3 | 2020 | 870 | 0.380 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2012 | 238 | 0.380 |
Why?
|
| Risk Assessment | 19 | 2021 | 24279 | 0.380 |
Why?
|
| Social Class | 1 | 2020 | 2007 | 0.380 |
Why?
|
| Odds Ratio | 20 | 2021 | 9647 | 0.370 |
Why?
|
| Cooking | 1 | 2014 | 327 | 0.370 |
Why?
|
| Incidence | 26 | 2024 | 21478 | 0.370 |
Why?
|
| Reproducibility of Results | 17 | 2024 | 20120 | 0.370 |
Why?
|
| Hyperglycemia | 3 | 2024 | 1392 | 0.370 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2022 | 538 | 0.370 |
Why?
|
| Recreation | 2 | 2022 | 125 | 0.360 |
Why?
|
| Creatinine | 2 | 2016 | 1915 | 0.360 |
Why?
|
| Behavior, Addictive | 1 | 2016 | 423 | 0.360 |
Why?
|
| Abortion, Spontaneous | 1 | 2015 | 535 | 0.350 |
Why?
|
| Quantitative Trait Loci | 10 | 2021 | 2137 | 0.340 |
Why?
|
| Basal Metabolism | 1 | 2011 | 163 | 0.340 |
Why?
|
| Urban Population | 6 | 2021 | 2040 | 0.340 |
Why?
|
| Body Weight | 10 | 2020 | 4624 | 0.340 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2012 | 558 | 0.340 |
Why?
|
| Netherlands | 12 | 2015 | 2277 | 0.330 |
Why?
|
| Food | 4 | 2024 | 764 | 0.330 |
Why?
|
| Linear Models | 13 | 2017 | 5876 | 0.330 |
Why?
|
| Insulin | 10 | 2024 | 6601 | 0.320 |
Why?
|
| Reading | 1 | 2013 | 540 | 0.320 |
Why?
|
| Calcifediol | 2 | 2007 | 156 | 0.320 |
Why?
|
| Electrowetting | 2 | 2019 | 2 | 0.320 |
Why?
|
| Temperature | 1 | 2015 | 2226 | 0.310 |
Why?
|
| Patient Compliance | 4 | 2016 | 2692 | 0.310 |
Why?
|
| Alcohol Drinking | 9 | 2019 | 4041 | 0.310 |
Why?
|
| Diabetes, Gestational | 5 | 2020 | 1263 | 0.310 |
Why?
|
| Cadherins | 1 | 2013 | 900 | 0.310 |
Why?
|
| Vitamin D | 8 | 2016 | 3272 | 0.310 |
Why?
|
| Mortality | 5 | 2020 | 2904 | 0.300 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 541 | 0.300 |
Why?
|
| Aged, 80 and over | 33 | 2021 | 59459 | 0.300 |
Why?
|
| Vitamin B 12 | 3 | 2017 | 531 | 0.300 |
Why?
|
| Dementia | 1 | 2022 | 2745 | 0.290 |
Why?
|
| Bandages | 1 | 2010 | 269 | 0.290 |
Why?
|
| Alkaloids | 1 | 2009 | 191 | 0.290 |
Why?
|
| Gender Identity | 1 | 2014 | 766 | 0.290 |
Why?
|
| Cross-Over Studies | 4 | 2019 | 2108 | 0.290 |
Why?
|
| Satiation | 1 | 2007 | 84 | 0.280 |
Why?
|
| Calcium, Dietary | 3 | 2007 | 526 | 0.280 |
Why?
|
| Gestational Age | 3 | 2016 | 3612 | 0.280 |
Why?
|
| Premature Birth | 4 | 2016 | 1829 | 0.280 |
Why?
|
| Benzamides | 3 | 2019 | 1376 | 0.280 |
Why?
|
| Weight Loss | 3 | 2023 | 2710 | 0.280 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 67 | 0.270 |
Why?
|
| Hypertension | 8 | 2024 | 8626 | 0.270 |
Why?
|
| Lipoproteins, LDL | 3 | 2020 | 643 | 0.270 |
Why?
|
| Adolescent | 32 | 2022 | 88781 | 0.270 |
Why?
|
| Endothelium, Vascular | 4 | 2013 | 4423 | 0.270 |
Why?
|
| Diabetic Angiopathies | 2 | 2009 | 805 | 0.270 |
Why?
|
| Carbohydrate Metabolism | 1 | 2007 | 261 | 0.270 |
Why?
|
| Focus Groups | 6 | 2020 | 1459 | 0.270 |
Why?
|
| Cognition | 5 | 2023 | 7048 | 0.270 |
Why?
|
| Energy Metabolism | 5 | 2021 | 2891 | 0.260 |
Why?
|
| Pregnancy | 21 | 2020 | 30248 | 0.260 |
Why?
|
| Mental Health | 1 | 2020 | 3272 | 0.260 |
Why?
|
| Dyslipidemias | 3 | 2021 | 869 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2017 | 2531 | 0.260 |
Why?
|
| Acute-Phase Proteins | 1 | 2007 | 252 | 0.250 |
Why?
|
| Marketing | 2 | 2024 | 225 | 0.250 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3000 | 0.250 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 160 | 0.240 |
Why?
|
| Estradiol | 1 | 2012 | 1947 | 0.240 |
Why?
|
| Interviews as Topic | 5 | 2019 | 2740 | 0.240 |
Why?
|
| Food Handling | 3 | 2022 | 158 | 0.240 |
Why?
|
| Health Surveys | 6 | 2020 | 4057 | 0.240 |
Why?
|
| Physical Fitness | 2 | 2007 | 742 | 0.240 |
Why?
|
| Dairy Products | 4 | 2011 | 491 | 0.240 |
Why?
|
| Genotype | 18 | 2024 | 13024 | 0.230 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 2967 | 0.230 |
Why?
|
| Multivariate Analysis | 16 | 2019 | 12056 | 0.230 |
Why?
|
| Diabetic Nephropathies | 3 | 2024 | 969 | 0.230 |
Why?
|
| Food Industry | 1 | 2024 | 68 | 0.230 |
Why?
|
| Employment | 3 | 2024 | 1107 | 0.230 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2000 | 562 | 0.220 |
Why?
|
| Walking | 3 | 2021 | 1198 | 0.220 |
Why?
|
| Pyrophosphatases | 1 | 2024 | 141 | 0.220 |
Why?
|
| Body Composition | 7 | 2020 | 2441 | 0.220 |
Why?
|
| Commerce | 2 | 2020 | 611 | 0.220 |
Why?
|
| Body Size | 3 | 2019 | 459 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2017 | 1899 | 0.220 |
Why?
|
| Quality Control | 4 | 2014 | 835 | 0.220 |
Why?
|
| Body Height | 3 | 2022 | 1561 | 0.220 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2024 | 204 | 0.220 |
Why?
|
| Linkage Disequilibrium | 10 | 2022 | 1996 | 0.220 |
Why?
|
| Inflammation | 9 | 2023 | 10846 | 0.220 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 2129 | 0.210 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2005 | 357 | 0.210 |
Why?
|
| Thromboembolism | 1 | 2010 | 1003 | 0.210 |
Why?
|
| Social Desirability | 1 | 2023 | 45 | 0.210 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2020 | 1039 | 0.210 |
Why?
|
| Asia | 4 | 2024 | 628 | 0.210 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 9 | 0.210 |
Why?
|
| Chromosome Mapping | 3 | 2022 | 4618 | 0.210 |
Why?
|
| Time Factors | 13 | 2020 | 40066 | 0.210 |
Why?
|
| Family | 1 | 2014 | 3207 | 0.200 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 710 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7424 | 0.200 |
Why?
|
| E-Selectin | 4 | 2010 | 576 | 0.200 |
Why?
|
| Heparin | 1 | 2010 | 1630 | 0.200 |
Why?
|
| Meta-Analysis as Topic | 5 | 2013 | 1367 | 0.200 |
Why?
|
| Ceramides | 2 | 2020 | 201 | 0.200 |
Why?
|
| Leukocytes | 2 | 2021 | 2027 | 0.190 |
Why?
|
| Linoleic Acid | 2 | 2019 | 157 | 0.190 |
Why?
|
| Milk | 2 | 2017 | 436 | 0.190 |
Why?
|
| Neoplasms | 10 | 2021 | 22345 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2017 | 10730 | 0.190 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 3109 | 0.190 |
Why?
|
| Testosterone | 1 | 2012 | 2495 | 0.190 |
Why?
|
| Cacao | 2 | 2013 | 98 | 0.190 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 475 | 0.190 |
Why?
|
| Homeostasis | 3 | 2023 | 3336 | 0.180 |
Why?
|
| United States | 31 | 2017 | 72898 | 0.180 |
Why?
|
| Prevalence | 10 | 2020 | 15833 | 0.180 |
Why?
|
| Plant Proteins | 1 | 2023 | 375 | 0.180 |
Why?
|
| Water | 3 | 2022 | 1418 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2014 | 1526 | 0.170 |
Why?
|
| Telomere-Binding Proteins | 1 | 2021 | 122 | 0.170 |
Why?
|
| Macular Degeneration | 2 | 2020 | 1001 | 0.170 |
Why?
|
| Logistic Models | 12 | 2021 | 13261 | 0.170 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2020 | 150 | 0.170 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 14745 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3584 | 0.170 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2586 | 0.170 |
Why?
|
| Decision Making | 1 | 2014 | 3964 | 0.170 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 1295 | 0.160 |
Why?
|
| Online Systems | 1 | 2020 | 181 | 0.160 |
Why?
|
| Acetonitriles | 2 | 2019 | 55 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 4520 | 0.160 |
Why?
|
| Carnitine | 1 | 2020 | 254 | 0.160 |
Why?
|
| Socioeconomic Factors | 5 | 2019 | 7835 | 0.160 |
Why?
|
| Fast Foods | 2 | 2022 | 220 | 0.160 |
Why?
|
| Weaning | 2 | 2017 | 103 | 0.160 |
Why?
|
| Radiometry | 2 | 2018 | 804 | 0.160 |
Why?
|
| Surface-Active Agents | 1 | 2019 | 150 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 983 | 0.160 |
Why?
|
| Interleukin-18 | 2 | 2011 | 251 | 0.150 |
Why?
|
| Gene Frequency | 8 | 2022 | 3623 | 0.150 |
Why?
|
| Attitude to Computers | 1 | 2019 | 196 | 0.150 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2020 | 209 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 2309 | 0.150 |
Why?
|
| Self Report | 5 | 2023 | 3772 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2023 | 378 | 0.150 |
Why?
|
| Drug Resistance, Multiple | 1 | 2019 | 255 | 0.150 |
Why?
|
| Comorbidity | 7 | 2022 | 10567 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2021 | 820 | 0.150 |
Why?
|
| Brassicaceae | 1 | 2018 | 10 | 0.150 |
Why?
|
| Abdominal Fat | 3 | 2015 | 217 | 0.150 |
Why?
|
| Pregnancy Complications | 4 | 2017 | 2969 | 0.150 |
Why?
|
| Receptors, Leptin | 2 | 2010 | 355 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 1941 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2011 | 347 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 2495 | 0.150 |
Why?
|
| Breast Feeding | 2 | 2017 | 1363 | 0.150 |
Why?
|
| Phenotype | 14 | 2023 | 16706 | 0.150 |
Why?
|
| Infant Behavior | 1 | 2019 | 156 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.140 |
Why?
|
| Consanguinity | 1 | 2019 | 460 | 0.140 |
Why?
|
| Universities | 2 | 2024 | 1000 | 0.140 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2018 | 91 | 0.140 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 1892 | 0.140 |
Why?
|
| Pyrrolidines | 1 | 2019 | 337 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 898 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6219 | 0.140 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 237 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 304 | 0.140 |
Why?
|
| Physical Exertion | 1 | 2020 | 665 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2511 | 0.140 |
Why?
|
| Motor Activity | 6 | 2015 | 2705 | 0.140 |
Why?
|
| Multifactorial Inheritance | 5 | 2024 | 1425 | 0.130 |
Why?
|
| Fishes | 2 | 2017 | 607 | 0.130 |
Why?
|
| Parents | 4 | 2020 | 3592 | 0.130 |
Why?
|
| Automation | 1 | 2019 | 585 | 0.130 |
Why?
|
| DNA Repair | 2 | 2019 | 2051 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2740 | 0.130 |
Why?
|
| PPAR delta | 1 | 2016 | 40 | 0.130 |
Why?
|
| Intention | 1 | 2019 | 346 | 0.130 |
Why?
|
| Feedback | 1 | 2020 | 796 | 0.130 |
Why?
|
| Qualitative Research | 4 | 2020 | 3138 | 0.130 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 407 | 0.130 |
Why?
|
| Self Disclosure | 2 | 2008 | 248 | 0.130 |
Why?
|
| Caprylates | 1 | 2016 | 114 | 0.130 |
Why?
|
| Regression Analysis | 6 | 2020 | 6319 | 0.130 |
Why?
|
| Sex Factors | 9 | 2017 | 10605 | 0.130 |
Why?
|
| Phosphotransferases | 1 | 2017 | 302 | 0.130 |
Why?
|
| Phytoestrogens | 1 | 2016 | 59 | 0.130 |
Why?
|
| Infant Nutrition Disorders | 1 | 2016 | 70 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 119 | 0.130 |
Why?
|
| Carotenoids | 1 | 2019 | 619 | 0.130 |
Why?
|
| Telemedicine | 3 | 2024 | 3105 | 0.130 |
Why?
|
| Polymorphism, Genetic | 5 | 2020 | 4249 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 338 | 0.130 |
Why?
|
| Alleles | 7 | 2021 | 6893 | 0.130 |
Why?
|
| Caffeic Acids | 1 | 2015 | 9 | 0.120 |
Why?
|
| Coumaric Acids | 1 | 2015 | 13 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2021 | 10385 | 0.120 |
Why?
|
| Nuts | 1 | 2017 | 265 | 0.120 |
Why?
|
| Fasting | 3 | 2013 | 1606 | 0.120 |
Why?
|
| Hesperidin | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
| Animals | 19 | 2024 | 168731 | 0.120 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 3684 | 0.120 |
Why?
|
| Flavanones | 1 | 2015 | 75 | 0.120 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2015 | 84 | 0.120 |
Why?
|
| Catechin | 1 | 2015 | 69 | 0.120 |
Why?
|
| Aryldialkylphosphatase | 1 | 2015 | 64 | 0.120 |
Why?
|
| Age Factors | 13 | 2021 | 18375 | 0.120 |
Why?
|
| Alcohols | 1 | 2015 | 94 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Fertility | 1 | 2019 | 768 | 0.120 |
Why?
|
| Metformin | 1 | 2022 | 904 | 0.120 |
Why?
|
| Quercetin | 1 | 2015 | 97 | 0.120 |
Why?
|
| Dihydrotestosterone | 1 | 2015 | 193 | 0.120 |
Why?
|
| Food Supply | 1 | 2020 | 544 | 0.110 |
Why?
|
| Trigonella | 1 | 2014 | 3 | 0.110 |
Why?
|
| Alkanesulfonic Acids | 1 | 2016 | 199 | 0.110 |
Why?
|
| Students | 1 | 2024 | 1736 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2011 | 3229 | 0.110 |
Why?
|
| Educational Status | 4 | 2019 | 2513 | 0.110 |
Why?
|
| Specimen Handling | 2 | 2015 | 703 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2015 | 580 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2010 | 4862 | 0.110 |
Why?
|
| Radioisotopes | 1 | 2015 | 495 | 0.110 |
Why?
|
| Trans Fatty Acids | 1 | 2015 | 155 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2019 | 1021 | 0.110 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 15390 | 0.110 |
Why?
|
| Vitamin D Deficiency | 2 | 2016 | 1349 | 0.110 |
Why?
|
| Social Stigma | 1 | 2020 | 788 | 0.110 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2013 | 11 | 0.110 |
Why?
|
| Catalysis | 1 | 2015 | 770 | 0.110 |
Why?
|
| Camellia sinensis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 737 | 0.110 |
Why?
|
| Oxygen Radioisotopes | 1 | 2013 | 60 | 0.110 |
Why?
|
| Video Games | 1 | 2016 | 202 | 0.110 |
Why?
|
| Urbanization | 1 | 2014 | 100 | 0.110 |
Why?
|
| Economic Development | 1 | 2014 | 72 | 0.100 |
Why?
|
| Child Behavior | 2 | 2016 | 865 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2016 | 370 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2020 | 2666 | 0.100 |
Why?
|
| Equipment Reuse | 1 | 2013 | 45 | 0.100 |
Why?
|
| Telomere | 1 | 2019 | 941 | 0.100 |
Why?
|
| Electrochemistry | 1 | 2013 | 142 | 0.100 |
Why?
|
| Mice | 9 | 2024 | 81792 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1525 | 0.100 |
Why?
|
| Child Care | 1 | 2014 | 126 | 0.100 |
Why?
|
| Heart | 2 | 2024 | 4417 | 0.100 |
Why?
|
| Myocardium | 2 | 2024 | 4763 | 0.100 |
Why?
|
| Flavonols | 1 | 2013 | 85 | 0.100 |
Why?
|
| Milk, Human | 1 | 2017 | 490 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 4 | 2011 | 1167 | 0.100 |
Why?
|
| Seafood | 1 | 2015 | 395 | 0.100 |
Why?
|
| Pyrus | 1 | 2012 | 14 | 0.100 |
Why?
|
| Health Status | 2 | 2019 | 4081 | 0.100 |
Why?
|
| Fluorides | 1 | 2013 | 134 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 3 | 2008 | 999 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 220 | 0.100 |
Why?
|
| Infant, Newborn | 9 | 2020 | 26332 | 0.100 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 353 | 0.100 |
Why?
|
| Validation Studies as Topic | 2 | 2012 | 162 | 0.100 |
Why?
|
| Chemistry, Clinical | 1 | 2012 | 64 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2014 | 299 | 0.100 |
Why?
|
| Nurses | 6 | 2015 | 2505 | 0.090 |
Why?
|
| Malus | 1 | 2012 | 50 | 0.090 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 660 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 14637 | 0.090 |
Why?
|
| Sex Characteristics | 4 | 2022 | 2643 | 0.090 |
Why?
|
| Retinal Vein | 1 | 2011 | 46 | 0.090 |
Why?
|
| Menopause, Premature | 1 | 2013 | 124 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2019 | 1187 | 0.090 |
Why?
|
| Adipose Tissue | 4 | 2008 | 3313 | 0.090 |
Why?
|
| Food Analysis | 2 | 2020 | 104 | 0.090 |
Why?
|
| Vitamins | 1 | 2000 | 1632 | 0.090 |
Why?
|
| Fluorocarbons | 1 | 2016 | 497 | 0.090 |
Why?
|
| Republic of Korea | 1 | 2013 | 588 | 0.090 |
Why?
|
| Canada | 1 | 2016 | 2119 | 0.090 |
Why?
|
| Hypercholesterolemia | 3 | 2011 | 1149 | 0.090 |
Why?
|
| Indonesia | 1 | 2011 | 131 | 0.090 |
Why?
|
| Confidence Intervals | 3 | 2011 | 2910 | 0.090 |
Why?
|
| Social Environment | 1 | 2016 | 1011 | 0.090 |
Why?
|
| Epidemiologic Methods | 4 | 2013 | 1325 | 0.090 |
Why?
|
| Retinal Artery | 1 | 2011 | 109 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2015 | 1885 | 0.090 |
Why?
|
| Ubiquinone | 1 | 2012 | 181 | 0.090 |
Why?
|
| Plant Preparations | 1 | 2011 | 93 | 0.090 |
Why?
|
| Equipment Design | 3 | 2015 | 3485 | 0.090 |
Why?
|
| Electrodes | 1 | 2013 | 609 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 311 | 0.090 |
Why?
|
| Postpartum Period | 2 | 2017 | 1200 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 803 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2014 | 498 | 0.090 |
Why?
|
| Critical Illness | 2 | 2016 | 2744 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2349 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2000 | 5824 | 0.080 |
Why?
|
| Environment Design | 2 | 2022 | 174 | 0.080 |
Why?
|
| Malnutrition | 1 | 2016 | 628 | 0.080 |
Why?
|
| Genome, Human | 4 | 2022 | 4446 | 0.080 |
Why?
|
| Hand Strength | 2 | 2023 | 462 | 0.080 |
Why?
|
| Photometry | 1 | 2009 | 56 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 361 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 1 | 2016 | 916 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 1429 | 0.080 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 949 | 0.080 |
Why?
|
| Depression, Postpartum | 1 | 2014 | 356 | 0.080 |
Why?
|
| Avitaminosis | 1 | 2009 | 35 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Japan | 1 | 2013 | 1415 | 0.080 |
Why?
|
| Child | 7 | 2021 | 80499 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 1601 | 0.080 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 23 | 0.080 |
Why?
|
| Mannitol | 1 | 2009 | 176 | 0.080 |
Why?
|
| Robotics | 1 | 2015 | 808 | 0.080 |
Why?
|
| Transients and Migrants | 1 | 2011 | 170 | 0.080 |
Why?
|
| Prognosis | 6 | 2019 | 29899 | 0.070 |
Why?
|
| Nutrition Surveys | 3 | 2017 | 1741 | 0.070 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2328 | 0.070 |
Why?
|
| Minority Groups | 1 | 2015 | 1208 | 0.070 |
Why?
|
| Menarche | 1 | 2010 | 532 | 0.070 |
Why?
|
| Resistin | 1 | 2008 | 174 | 0.070 |
Why?
|
| Vitamin E | 1 | 2012 | 869 | 0.070 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2010 | 263 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1175 | 0.070 |
Why?
|
| ABO Blood-Group System | 1 | 2010 | 380 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2019 | 2190 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15749 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2016 | 1291 | 0.070 |
Why?
|
| Haplotypes | 3 | 2022 | 2728 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2007 | 126 | 0.070 |
Why?
|
| Mothers | 2 | 2017 | 2209 | 0.070 |
Why?
|
| Tunica Intima | 1 | 2009 | 455 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 145 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3097 | 0.070 |
Why?
|
| Disease Progression | 1 | 2024 | 13614 | 0.070 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 523 | 0.070 |
Why?
|
| Actigraphy | 1 | 2010 | 531 | 0.070 |
Why?
|
| Calcinosis | 1 | 2015 | 1477 | 0.070 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2007 | 94 | 0.070 |
Why?
|
| Europe | 3 | 2022 | 3423 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 137 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 21053 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 17062 | 0.060 |
Why?
|
| Population Groups | 2 | 2021 | 209 | 0.060 |
Why?
|
| Lipocalins | 1 | 2007 | 162 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 634 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2007 | 417 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2845 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2021 | 4425 | 0.060 |
Why?
|
| Immunity | 1 | 2012 | 1002 | 0.060 |
Why?
|
| Women's Health | 1 | 2015 | 2083 | 0.060 |
Why?
|
| Genistein | 2 | 2016 | 87 | 0.060 |
Why?
|
| Fetal Development | 1 | 2011 | 777 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3691 | 0.060 |
Why?
|
| Hip Fractures | 1 | 2014 | 997 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3230 | 0.060 |
Why?
|
| Calcium | 1 | 2018 | 5765 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1670 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2023 | 8062 | 0.060 |
Why?
|
| Heme | 1 | 2007 | 316 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4352 | 0.060 |
Why?
|
| Zinc | 1 | 2009 | 675 | 0.060 |
Why?
|
| Placebos | 1 | 2009 | 1659 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2009 | 929 | 0.060 |
Why?
|
| Membrane Proteins | 3 | 2019 | 7849 | 0.060 |
Why?
|
| Poultry | 1 | 2024 | 79 | 0.060 |
Why?
|
| Epidemiologic Studies | 1 | 2008 | 677 | 0.060 |
Why?
|
| Sample Size | 2 | 2022 | 843 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 1707 | 0.060 |
Why?
|
| Awareness | 2 | 2020 | 653 | 0.060 |
Why?
|
| Infant | 8 | 2019 | 36363 | 0.060 |
Why?
|
| Leptin | 2 | 2009 | 1597 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2019 | 2266 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11888 | 0.060 |
Why?
|
| Glucose Clamp Technique | 1 | 2024 | 262 | 0.060 |
Why?
|
| Communication | 1 | 2018 | 3914 | 0.060 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1349 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 483 | 0.060 |
Why?
|
| Sweetening Agents | 2 | 2019 | 291 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8038 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 459 | 0.050 |
Why?
|
| Menopause | 1 | 2012 | 1661 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5442 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2015 | 1962 | 0.050 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 345 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 79 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2022 | 30 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2016 | 8732 | 0.050 |
Why?
|
| Amylases | 1 | 2023 | 171 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 1185 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1456 | 0.050 |
Why?
|
| Causality | 1 | 2008 | 1246 | 0.050 |
Why?
|
| Liver | 3 | 2021 | 7559 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2015 | 6252 | 0.050 |
Why?
|
| Public Facilities | 1 | 2022 | 34 | 0.050 |
Why?
|
| Suriname | 2 | 2011 | 28 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2009 | 861 | 0.050 |
Why?
|
| Internet | 2 | 2024 | 3103 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 2009 | 896 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 165 | 0.050 |
Why?
|
| Emotions | 1 | 2013 | 2764 | 0.050 |
Why?
|
| Genetic Pleiotropy | 1 | 2022 | 182 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3712 | 0.050 |
Why?
|
| Aging | 3 | 2010 | 8730 | 0.050 |
Why?
|
| Chromatin | 2 | 2024 | 2981 | 0.050 |
Why?
|
| Adipocytes | 2 | 2024 | 1193 | 0.050 |
Why?
|
| Elliptocytosis, Hereditary | 1 | 2020 | 28 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1885 | 0.050 |
Why?
|
| Proteins | 3 | 2014 | 5996 | 0.050 |
Why?
|
| Genetics, Population | 2 | 2021 | 943 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Income | 1 | 2009 | 1874 | 0.040 |
Why?
|
| Depression | 2 | 2011 | 8230 | 0.040 |
Why?
|
| Heart Failure | 2 | 2023 | 11840 | 0.040 |
Why?
|
| Morocco | 2 | 2011 | 36 | 0.040 |
Why?
|
| Mass Screening | 1 | 2016 | 5445 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 334 | 0.040 |
Why?
|
| Longevity | 1 | 2008 | 1087 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2007 | 1316 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2021 | 1751 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 398 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4459 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 834 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 123 | 0.040 |
Why?
|
| Health Personnel | 2 | 2011 | 3390 | 0.040 |
Why?
|
| Buffers | 1 | 2019 | 141 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2021 | 189 | 0.040 |
Why?
|
| Play and Playthings | 1 | 2020 | 85 | 0.040 |
Why?
|
| Ethylene Glycol | 1 | 2019 | 31 | 0.040 |
Why?
|
| Belgium | 1 | 2019 | 119 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 25 | 0.040 |
Why?
|
| Boston | 1 | 2012 | 9337 | 0.040 |
Why?
|
| Turkey | 2 | 2011 | 281 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4417 | 0.040 |
Why?
|
| Uromodulin | 1 | 2019 | 49 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 388 | 0.040 |
Why?
|
| Beer | 1 | 2019 | 134 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 106 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 184 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2019 | 102 | 0.040 |
Why?
|
| Greece | 1 | 2019 | 341 | 0.040 |
Why?
|
| Breast | 1 | 2008 | 1946 | 0.040 |
Why?
|
| New Zealand | 1 | 2019 | 359 | 0.040 |
Why?
|
| Proxy | 1 | 2020 | 151 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 951 | 0.040 |
Why?
|
| Silicon | 1 | 2019 | 141 | 0.040 |
Why?
|
| Wine | 1 | 2019 | 172 | 0.040 |
Why?
|
| Cities | 1 | 2021 | 543 | 0.040 |
Why?
|
| Genetic Heterogeneity | 2 | 2014 | 735 | 0.040 |
Why?
|
| Ions | 1 | 2019 | 254 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 1789 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2019 | 250 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12433 | 0.040 |
Why?
|
| Molecular Epidemiology | 2 | 2011 | 472 | 0.040 |
Why?
|
| Finland | 1 | 2019 | 608 | 0.040 |
Why?
|
| Iron | 1 | 2007 | 1814 | 0.040 |
Why?
|
| Saliva | 1 | 2023 | 851 | 0.040 |
Why?
|
| Antiporters | 1 | 2019 | 275 | 0.040 |
Why?
|
| Epigenomics | 1 | 2024 | 959 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 391 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2021 | 6203 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2006 | 1078 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 3 | 2016 | 2685 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 268 | 0.040 |
Why?
|
| Postmenopause | 3 | 2015 | 2516 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2017 | 115 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2020 | 42468 | 0.040 |
Why?
|
| Sunlight | 1 | 1999 | 336 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2020 | 588 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2018 | 223 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4909 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20667 | 0.040 |
Why?
|
| Mass Media | 1 | 2020 | 301 | 0.040 |
Why?
|
| Sphingosine | 1 | 2019 | 306 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2017 | 34 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 683 | 0.030 |
Why?
|
| Federal Government | 1 | 2019 | 265 | 0.030 |
Why?
|
| Thymidine | 1 | 2017 | 294 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 4391 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1669 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2020 | 628 | 0.030 |
Why?
|
| Research Design | 2 | 2024 | 6207 | 0.030 |
Why?
|
| Australia | 1 | 2020 | 1258 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 6952 | 0.030 |
Why?
|
| Skinfold Thickness | 1 | 2016 | 164 | 0.030 |
Why?
|
| Attitude | 1 | 2021 | 770 | 0.030 |
Why?
|
| Metabolome | 1 | 2023 | 1005 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 801 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1670 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 935 | 0.030 |
Why?
|
| Diastole | 1 | 2018 | 785 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 990 | 0.030 |
Why?
|
| Food Contamination | 1 | 2016 | 194 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2010 | 3459 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2007 | 2040 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 241 | 0.030 |
Why?
|
| Snoring | 1 | 2016 | 212 | 0.030 |
Why?
|
| Keratins | 1 | 2016 | 497 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1774 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1248 | 0.030 |
Why?
|
| Iran | 1 | 2017 | 762 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 574 | 0.030 |
Why?
|
| Environment | 2 | 2011 | 1115 | 0.030 |
Why?
|
| Solid Phase Extraction | 1 | 2014 | 28 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2015 | 111 | 0.030 |
Why?
|
| Soybean Proteins | 1 | 2014 | 55 | 0.030 |
Why?
|
| Health Communication | 1 | 2017 | 216 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1077 | 0.030 |
Why?
|
| Rheology | 1 | 2015 | 348 | 0.030 |
Why?
|
| Homocysteine | 1 | 2017 | 638 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1065 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1668 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 1160 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2016 | 469 | 0.030 |
Why?
|
| Genomics | 2 | 2022 | 5924 | 0.030 |
Why?
|
| Nuclear Family | 1 | 2014 | 311 | 0.030 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 124 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 1081 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Proteome | 1 | 2023 | 1897 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 856 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2024 | 5302 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3805 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2007 | 1132 | 0.030 |
Why?
|
| Maternal Age | 1 | 2015 | 804 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1639 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 674 | 0.030 |
Why?
|
| Brain | 2 | 2017 | 27178 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3446 | 0.030 |
Why?
|
| Parity | 1 | 2015 | 931 | 0.020 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 104 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1311 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2538 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 6018 | 0.020 |
Why?
|
| Benchmarking | 1 | 2019 | 1053 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2017 | 1001 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2014 | 386 | 0.020 |
Why?
|
| Neck | 1 | 2016 | 733 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 321 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2261 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 1008 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2012 | 209 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 2415 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 490 | 0.020 |
Why?
|
| Schools | 1 | 2020 | 1492 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2016 | 775 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 2427 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9522 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 605 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4524 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3614 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2233 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 1470 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 265 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 103 | 0.020 |
Why?
|
| Cyprus | 1 | 2010 | 96 | 0.020 |
Why?
|
| Drug Design | 1 | 2015 | 1042 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 342 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2020 | 12123 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 920 | 0.020 |
Why?
|
| Health Policy | 1 | 2022 | 2699 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4772 | 0.020 |
Why?
|
| Beta Particles | 1 | 2009 | 52 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3558 | 0.020 |
Why?
|
| Intensive Care Units | 2 | 2016 | 3800 | 0.020 |
Why?
|
| Motivation | 1 | 2019 | 2020 | 0.020 |
Why?
|
| Biological Factors | 1 | 2010 | 155 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 175 | 0.020 |
Why?
|
| Africa | 1 | 2011 | 725 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2794 | 0.020 |
Why?
|
| Marital Status | 1 | 2010 | 426 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2002 | 0.020 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 415 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 1206 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 9071 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 222 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 482 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3432 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6109 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 11080 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1078 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3818 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2020 | 3592 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 798 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.020 |
Why?
|
| Women | 1 | 2009 | 226 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6001 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1736 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 852 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2009 | 898 | 0.020 |
Why?
|
| Body Constitution | 1 | 2006 | 272 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7599 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 405 | 0.020 |
Why?
|
| Adipokines | 1 | 2008 | 308 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2008 | 2163 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2006 | 152 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15883 | 0.020 |
Why?
|
| Developed Countries | 1 | 2009 | 452 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2007 | 165 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1213 | 0.020 |
Why?
|
| Risk Management | 1 | 2009 | 559 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 12769 | 0.020 |
Why?
|
| Drinking | 1 | 2006 | 196 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 1118 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2896 | 0.010 |
Why?
|
| Premenopause | 1 | 2008 | 1038 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14445 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1511 | 0.010 |
Why?
|
| Light | 1 | 2009 | 1364 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5125 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15542 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2016 | 5088 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2045 | 0.010 |
Why?
|
| Data Collection | 1 | 2011 | 3318 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2454 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1876 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 2056 | 0.010 |
Why?
|
| Mutation | 2 | 2017 | 30184 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2009 | 1944 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 2878 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7200 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2880 | 0.010 |
Why?
|
| Seasons | 1 | 2006 | 1522 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2010 | 3447 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 791 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2002 | 402 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 7584 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8279 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2899 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2011 | 2820 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2002 | 770 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11007 | 0.010 |
Why?
|
| World Health Organization | 1 | 2002 | 1327 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10069 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2009 | 5343 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 8498 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 5772 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9594 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18972 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 22321 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65180 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2010 | 81457 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23589 | 0.000 |
Why?
|